AME vs APGE · P/E 30, rev $2.04B vs $2.34B cap
Ametek Inc (AME) versus Apogee Therapeutics, Inc. Common Stock (APGE) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
APGE does not have a complete income-statement cache yet.
AME currently screens at market cap $42.11B and trailing P/E 29.9. APGE currently screens at market cap $2.34B.
Not investment advice. Open the AME and APGE stock pages for the full models.
Not investment advice.